Osman Fehmi Beyazal

Dr. Osman Fehmi Beyazal

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
EBEmre Boysan
Emre Boysan
RCRenda Circi
Renda Circi
OBOsman Fehmi Beyazal
Osman Fehmi Beyazal
EŞErol Şener
Erol Şener
Hypersensitivity reactions to heparin are uncommon conditions but pose a serious clinical problem for patients requiring cardiopulmonary bypass. Bivalirudin is a reversible direct thrombin inhibitor that can be used instead of heparin. A 49-year-old male patient was admitted to our hospital for coronary artery bypass graft operation with mitral insufficiency and tricuspid valve insufficiency. Heparin allergy was confirmed by skin biopsy and skin tests. Due to this allergy, we used bivalirudin (Bivacard VEM drug, Turkey) during the surgery. A loading dose of 1.0 mg/kg (100 mg) bivalirudin was administered through the central line and a continuous infusion of 2.5 mg/kg/h of the anticoagulant was initiated following the approved protocol. Serial ACTs were obtained at 15-minute intervals during the procedure and the measurements were 330s, 320s, 350s, 360s, and 340s consecutively. Additional boluses of 0.5 mg/kg (50 mg) were administered for each measurement. Left anterior descending, obtuse marginal arteries and the right coronary artery were grafted with the left internal mammary and saphenous veins. Also, mitral valve replacement with St Jude mechanical heart valve and tricuspid ring annuloplasty was performed with Medtronic Duran ring. After the surgery, the patient had an uneventful period in the postoperative intensive care unit with a total of 600ml and 300ml chest tube drainage for two days and was discharged on the 7th day. Alternative anticoagulation strategies are needed for cardiopulmonary bypass in patients unable to use heparin. Bivalirudin may be recommended as a viable alternative anticoagulant in patients with heparin allergy during cardiopulmonary bypass. However, each patient should be evaluated individually and it should not be forgotten that more than recommended doses may be needed.

8 May 2023 in Vascular
Verified
Journal Article
Closed access
OBOsman Fehmi Beyazal
Osman Fehmi Beyazal
The aim of this study is to evaluate the importance of complete blood count parameters for predicting deep vein thrombosis. Methods: It was planned as a retrospective case–control study in which 1,527 patients between January 2022 and September 2022 were evaluated. After the eligibility criteria, systematic sampling was performed and analyzed in the case group (103) and the control group (179) patients. The predictive significance of Hb, NLR, PLR, MPV, PLT, MPV/PLT, monocytes, lymphocytes, eosinophils, RDW, LMR, and PDW parameters for the development of DVT was investigated. Then, logistic regression analysis was performed with these parameters to analyze the predictive value. The cutoff point was determined by performing ROC analysis for the statistically significant parameters. Results: Neutrophil, RDW, PDW, NLR, and MPV/platelet values were statistically higher in the DVT group than the control group. Lymphocyte, PLT, and LMR values were statistically lower in the DVT group than the control group. There was no statistical difference between the two groups in terms of neutrophils, monocytes, eosinophils, Hb, MPV, and PLR values. RDW and PDW values were statistically significant for DVT prediction ( p < 0.001, OR = 1.183 and p < 0.001, OR = 1.304, respectively). According to ROC analysis, 45.5 fL for RDW and 14.3 fL for PDW were determined as the cutoff points for DVT prediction. Conclusion: We found RDW and PDW to be significant in terms of DVT prediction in our study. We found the NLR and MPV/PLT to be higher in the DVT group, and the LMR to be lower in the DVT group, but we found that there was no statistically significant predictive value. CBC can be used as an inexpensive and easily accessible test that has predictive significance for DVT. In addition, these findings need to be supported by prospective studies in the future.

1 January 2024 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
MKMustafa Karaarslan
Mustafa Karaarslan
OBOsman Fehmi Beyazal
Osman Fehmi Beyazal
MYMehmed Yanartaş
Mehmed Yanartaş
The aim of our study is to compare the early and mid-term outcomes of patients with hypertrophic obstructive cardiomyopathy who underwent classic and modified Morrow septal myectomy. Between 2014 and 2019, 48 patients (24 males; mean age 49.27±16.41 years) who underwent septal myectomy were evaluated. The patients were divided into two groups - those who underwent classic septal myectomy (n=28) and those who underwent modified septal myectomy (n=20). Mitral valve intervention was higher in the classic Morrow group than in the modified Morrow group, but there was no significant difference (P=0.42). Mortality was found to be lower in the modified Morrow group than in the classic Morrow group (P=0.01). In both groups, the mean immediate postoperative gradient was significantly higher than the mean of the 3rd and 12th postoperative months. The preoperative and postoperative gradient difference of the modified Morrow group was significantly higher than of the classic Morrow group (P<0.001). Classic Morrow and modified Morrow procedures are effective methods for reducing left ventricular outflow tract obstruction. The modified Morrow procedure was found to be superior to the classic Morrow procedure in terms of reducing the incidence of mitral valve intervention with the reduction of the left ventricular outflow tract gradient.

21 July 2025 in Turkish Journal of Vascular Surgery
Verified
Journal Article
Open access
PDF file
OBOsman Fehmi Beyazal
Osman Fehmi Beyazal
MYMehmed Yanartas
Mehmed Yanartas
Aim: The aim of this study is to investigate the relationship between statin use and deep vein thrombosis (DVT).Material and Methods: Between 2022 and 2024, 1833 patients (926 males; mean age 50.2±0.37 years) who applied to our clinic were included in the study. Following exclusion criteria, the patients were divided into two groups. Group A (n=226): patients diagnosed with DVT, and Group B (n=1607): Patients without DVT. Then, patients diagnosed with DVT (n=226) were divided into two separate subgroups. Group C (n=16): Statin users, and Group D (n=210): statin non-users. Comparisons were made between these groups in terms of demographic data, comorbidities, statin usage, laboratory parameters, and DVT localizations.Results: Statin usage was significantly lower in the DVT group than in the non-DVT group (16 (7.1%) and 184 (11.4%), respectively, p=0.04). In Group C, the incidence of DVT in the superficial femoral vein was higher than in Group D (p=0.03). Although no statistically significant difference was found, the incidence of DVT in the iliac veins was higher in Group D, while the incidence of DVT in the common femoral vein was higher in Group C. Similarly, rare localizations of DVT are more frequent in Group D than in Group C. DVTs in statin non-users tended to be more widespread than in statin users. A negative significant association was found between statin usage and DVT (p=0.001, OR= -0.084 [95% CI, -0.123–0.036].Conclusion: We determined that statin usage was lower in patients with DVT than in those without DVT. Statin usage may be protective against DVT. Although no statistically significant difference was found, DVTs in statin non-users tended to be more widespread than in statin users. We found that DVTs in statin non-users affected more proximal segments, whereas in statin users, more distal venous segments were affected.

16 July 2022 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
OBOsman Fehmi Beyazal
Osman Fehmi Beyazal
ÜKÜmit Kervan
Ümit Kervan
MKMehmet Karahan
Mehmet Karahan
SKSinan Sabit Kocabeyoğlu
Sinan Sabit Kocabeyoğlu
DSDoğan Emre Sert
Doğan Emre Sert
ZÇZeki Çatav
Zeki Çatav
Background: The aim of this study is to investigate the relationship of preoperative NT-proBNP values with postoperative adverse events in patient left ventricular assist device (LVAD) implantation. Method: Forty-six patients (35 males; mean age 49.4 ± 12.9 years) who underwent LVAD implantation between 2016 and 2018 were evaluated in this study. The analysis was made on the relationship between preoperative NT-proBNP and mortality, postoperative right ventricular failure (RVF), postoperative drainage, duration of intubation, and intensive care unit stay, was examined. The optimal NT-proBNP cut-off values for predicting mortality were determined using Receiver Operator Characteristic (ROC) curve analysis and the patients were divided into two groups according to the specified cut-off point. Result: Median NT-proBNP was higher in patients who died, had postoperative extracorporeal membrane oxygenation, and early RVF. The median NT-proBNP was 11,103 pg/ml in patients with IABP, and 2943 pg/ml in patients without IABP, and the difference was statistically significant ( p = 0.002). The cut-off point for NT-proBNP was found to be 1725.5 pg/ml (Sensitivity:0.929, Specificity:0.688). Accordingly, when the patients were divided into two groups and analyzed, no statistically significant difference was found between preoperative NT-proBNP below or above 1725.5 and postoperative adverse events. There was no statistically significant correlation between preoperative NT-proBNP and postoperative drainage, duration of intubation time, and duration of ICU stay ( p > 0.05). Conclusion: Routine monitoring of preoperative NT-proBNP and comparison with postoperative values are important in terms of patient selection, the timing of surgery, follow-up of postoperative adverse events, and improving outcomes in VAD patients.

7 January 2024 in Neuroimmunology Reports
Verified
Journal Article
Open access
OBOsman Fehmi Beyazal
Osman Fehmi Beyazal
FYFerhat Yıldız
Ferhat Yıldız
KAKoray Apaydın
Koray Apaydın
ZYZülfiye Yıldız
Zülfiye Yıldız
GSGültekin Saday
Gültekin Saday